Maximum quantity allowed is 999
Please select the quantity
CAS RN: 283173-50-2 | Product Number: R0284
Rucaparib
Purity: >95.0%(T)(HPLC)
Synonyms:
- 8-Fluoro-2-[4-[(methylamino)methyl]phenyl]-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one
Product Documents:
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Product Number | R0284 |
Purity / Analysis Method | >95.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__1__9H__1__8FN__3O = 323.37 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Frozen (-20°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Air Sensitive,Heat Sensitive |
Packaging and Container | 100MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 283173-50-2 |
Reaxys Registry Number | 11556434 |
MDL Number | MFCD11977252 |
Specifications
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 95.0 area% |
Purity(Nonaqueous Titration) | min. 95.0 % |
NMR | confirm to structure |
Properties (reference)
Melting Point | 220 °C(dec.) |
GHS
Pictogram | |
Signal Word | Danger |
Hazard Statements | H361 : Suspected of damaging fertility or the unborn child. H370 : Causes damage to organs. H372 : Causes damage to organs through prolonged or repeated exposure. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P260 : Do not breathe dust. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P311 : IF exposed or concerned: Call a POISON CENTER/doctor. P405 : Store locked up. |
Related Laws:
Transport Information:
H.S.code* | 2933.79-000 |
Application
Rucaparib: An Inhibitor of Poly (ADP-Ribose) Polymerase (PARP) Enzymes
Genomic instability is a hallmark of cancer and is often the result of altered DNA repair capabilities in tumor cells. Poly (ADP-ribose) polymerases (PARPs) are enzymes responsible for DNA damage detection and repair factor recruitment. PARP inhibitors are able to interact with the binding site for the PARP cofactor NAD+ and trap PARP on DNA, and induce cell death through replication stress-induced mitotic catastrophe. Rucaparib (AG014699; PF-01367338) has been reported as an inhibitor of PARP enzymes, including PARP-1, PARP-2 and PARP-3, which play a role in DNA repair. In vitro studies have shown that rucaparib-induced cytotoxicity may involve inhibition of PARP enzyme activity and increased formation of PARP-DNA complexes resulting in DNA damage, apoptosis, and cancer cell death. (The product is for research use only.)
References
- Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2
- Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
- Rucaparib: First Global Approval (a review)
- PARP and PARG inhibitors in cancer treatment (a review)
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.